NEW YORK ( TheStreet) -- Boston Scientific (NYSE: BSX) hit a new 52-week low Thursday as it is currently trading at $5.39, below its previous 52-week low of $5.41 with 15.6 million shares traded as of 9:50 a.m. ET. Average volume has been 19.8 million shares over the past 30 days.

Boston Scientific has a market cap of $8.7 billion and is part of the health care sector and health services industry. Shares are down 25.2% year to date as of the close of trading on Wednesday.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company has a P/E ratio of 14.2, above the average health services industry P/E ratio of 13.8 and below the S&P 500 P/E ratio of 17.7.
  • Practice your BSX trading strategies and win cash in our stock game.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth and attractive valuation levels. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. You can view the full Boston Scientific Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.